Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Metabolomic Biomarkers of Response to Neoadjuvant Chemoimmunotherapy in TNBC
NCT07847398Not yet recruiting
- Sponsor
- Centre Antoine Lacassagne
- Start
- Oct 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Antoine Lacassagne. Primary endpoints: Predictive performance of targeted metabolites and histological response at 8 months and Consistency of metabolites between plasma and tumor biopsies at 8 months. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07847398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07847398.